Details for New Drug Application (NDA): 212284
✉ Email this page to a colleague
NDA 212284 describes RANOLAZINE, which is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Ajanta Pharma Ltd, Alkem Labs Ltd, Amneal, Ani Pharms, Arthur Grp, Aurobindo Pharma, Cadila, Chartwell Rx, Cipla, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, I3 Pharms, Jubilant Generics, Mankind Pharma, Micro Labs, Novast Labs, Piramal, Rising, Sciegen Pharms Inc, Sun Pharm, Sunshine, Torrent, Unichem, and Vkt Pharma, and is included in twenty-six NDAs. It is available from twenty-seven suppliers. Additional details are available on the RANOLAZINE profile page.
The generic ingredient in RANOLAZINE is ranolazine. There are twenty-three drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ranolazine profile page.
The generic ingredient in RANOLAZINE is ranolazine. There are twenty-three drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ranolazine profile page.
Summary for 212284
| Tradename: | RANOLAZINE |
| Applicant: | Mankind Pharma |
| Ingredient: | ranolazine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 212284
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 212284 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8569 | 0615-8569-39 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8569-39) |
| RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 212284 | ANDA | Lifestar Pharma LLC | 70756-703 | 70756-703-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70756-703-60) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 500MG | ||||
| Approval Date: | Feb 12, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1GM | ||||
| Approval Date: | Feb 12, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
